Scarica l'app Stockscreener
8.31
30.87%
1.96
Precedente Chiudi:
$6.35
Aprire:
$6.35
Volume 24 ore:
3.84M
Relative Volume:
5.08
Capitalizzazione di mercato:
$570.35M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-3.8651
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+52.20%
1M Prestazione:
+54.75%
6M Prestazione:
+95.07%
1 anno Prestazione:
-29.75%
Intervallo 1D:
$6.35
$8.44
Intervallo di 1 settimana:
$5.36
$8.44
Portata 52W:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
8.31 | 435.83M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
What data driven models say about Olema Pharmaceuticals Inc.’s futureTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
What MACD and RSI say about Olema Pharmaceuticals Inc.Market Activity Report & Growth Oriented Trade Recommendations - Newser
Identifying reversal signals in Olema Pharmaceuticals Inc.July 2025 Opening Moves & Fast Moving Trade Plans - Newser
Signal strength of Olema Pharmaceuticals Inc. stock in tech scannersJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser
Will Olema Pharmaceuticals Inc. stock recover after earningsJuly 2025 Earnings & AI Enhanced Trading Alerts - خودرو بانک
Can Olema Pharmaceuticals Inc. maintain its current growth rate2025 Volume Leaders & Technical Buy Zone Confirmation - خودرو بانک
Is Olema Pharmaceuticals Inc. a play on infrastructure spendingJuly 2025 Chart Watch & Fast Gaining Stock Reports - خودرو بانک
Paradigm Biocapital Advisors LP Sells 563,798 Shares of Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Oppenheimer Reaffirms "Outperform" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals shares surge 20.49% intraday after announcing clinical trial collaboration with Pfizer for breast cancer treatment. - AInvest
How high can Olema Pharmaceuticals Inc. stock goJuly 2025 Setups & AI Enhanced Trading Signals - Newser
Olema Pharmaceuticals, Inc. $OLMA Shares Sold by BVF Inc. IL - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA is Bain Capital Life Sciences Investors LLC's 8th Largest Position - MarketBeat
Regression analysis insights on Olema Pharmaceuticals Inc. performanceJuly 2025 Update & Daily Entry Point Alerts - Newser
Multi factor analysis applied to Olema Pharmaceuticals Inc.Earnings Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
Olema Pharmaceuticals Inc. recovery potential after sell offQuarterly Market Review & Long Hold Capital Preservation Plans - Newser
Olema Pharmaceuticals Inc. stock outlook for YEAR2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser
Is Olema Pharmaceuticals Inc. trending in predictive chart modelsTrade Risk Assessment & Long-Term Safe Return Strategies - Newser
Is Olema Pharmaceuticals Inc. stock poised for growthJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
How to read the order book for Olema Pharmaceuticals Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Is Olema Pharmaceuticals Inc. a top pick in the sectorStock Surge & Safe Capital Growth Trade Ideas - خودرو بانک
Published on: 2025-09-05 21:58:24 - خودرو بانک
Why Olema Pharmaceuticals Inc. is moving todayJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser
Does Olema Pharmaceuticals Inc. outperform in volatile markets2025 Fundamental Recap & Smart Allocation Stock Reports - خودرو بانک
Pfizer collaboration with Olema may spark future bidding waranalyst - MSN
Olema Pharmaceuticals Inc. stock trendline breakdown2025 Analyst Calls & Long-Term Safe Investment Plans - Newser
Will Olema Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Price Swings & Daily Price Action Insights - خودرو بانک
Olema Oncology’s Strategic Use of Equity Incentives to Fuel R&D and Talent Growth - AInvest
Oppenheimer maintains Olema stock rating, sees Pfizer deal as strategic By Investing.com - Investing.com Canada
Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan - Quiver Quantitative
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
124,000 Shares: Olema Oncology Grants New Employee Stock Options with 4-Year Vesting Terms - Stock Titan
Wellington Management Group LLP Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Pfizer's partnership with Olema may spark a bidding war for the biotech firm. - AInvest
Pfizer (PFE) Partners With Olema For New Metastatic Breast Cancer Study - simplywall.st
Is Olema Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Intraday Action & Weekly Sector Rotation Insights - khodrobank.com
When is the best time to exit Olema Pharmaceuticals Inc.Gap Down & High Conviction Buy Zone Picks - Newser
H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on Olema Pharmaceuticals stock - Investing.com
How does Olema Pharmaceuticals Inc. correlate with NasdaqTrade Volume Summary & Safe Capital Allocation Plans - خودرو بانک
What technical models suggest about Olema Pharmaceuticals Inc.’s comeback2025 Top Gainers & Verified Short-Term Trading Plans - Newser
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):